Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van der Meer

Showing results (61-70 of 418) with videos related to

Pageof 42
Sort By:
Handbook of Experimental Pharmacology|April 7, 2017
Comorbidities in Heart FailureHaye H van der Wal, Vincent M van Deursen, Peter van der Meer, et al.
Expert Opinion on Investigational Drugs|June 23, 2015
Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney diseaseLicette C Y Liu, Elise Schutte, Ron T Gansevoort, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohortFrederik E Deiman, Remco de Brouwer, Lukas Baumhove, et al.
European Heart Journal|February 27, 2004
Erythropoietin in cardiovascular diseasesPeter van der Meer, Adriaan A Voors, Erik Lipsic, et al.
European Journal of Heart Failure|February 13, 2016
MicroRNAs in heart failure: from biomarker to target for therapyEline L Vegter, Peter van der Meer, Leon J de Windt, et al.
Journal of Cardiac Failure|May 14, 2026
Proton-pump inhibitor use as a modifiable etiological factor for iron deficiency in heart failureMats Kutscher, Haye H van der Wal, Adriaan A Voors, et al.
Stem Cell Reports|December 3, 2015
Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived CardiomyocytesJan David Kijlstra, Dongjian Hu, Nikhil Mittal, et al.
Npj Aging|January 23, 2024
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and agingAnnet Nicole Linders, Itamar Braga Dias, Teresa López Fernández, et al.
Journal of Clinical Medicine|January 11, 2022
Iron Deficiency in Heart Failure: Mechanisms and PathophysiologyRidha I S Alnuwaysir, Martijn F Hoes, Dirk J van Veldhuisen, et al.
JACC. Basic to Translational Science|September 19, 2024
Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER MalformationNienke M Stege, Rudolf A de Boer, Catherine A Makarewich, et al.
Pageof 42

Showing results (61-70 of 418) with videos related to

Sort By:
Pageof 42
Handbook of Experimental Pharmacology|April 7, 2017
Comorbidities in Heart FailureHaye H van der Wal, Vincent M van Deursen, Peter van der Meer, et al.
Expert Opinion on Investigational Drugs|June 23, 2015
Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney diseaseLicette C Y Liu, Elise Schutte, Ron T Gansevoort, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohortFrederik E Deiman, Remco de Brouwer, Lukas Baumhove, et al.
European Heart Journal|February 27, 2004
Erythropoietin in cardiovascular diseasesPeter van der Meer, Adriaan A Voors, Erik Lipsic, et al.
European Journal of Heart Failure|February 13, 2016
MicroRNAs in heart failure: from biomarker to target for therapyEline L Vegter, Peter van der Meer, Leon J de Windt, et al.
Journal of Cardiac Failure|May 14, 2026
Proton-pump inhibitor use as a modifiable etiological factor for iron deficiency in heart failureMats Kutscher, Haye H van der Wal, Adriaan A Voors, et al.
Stem Cell Reports|December 3, 2015
Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived CardiomyocytesJan David Kijlstra, Dongjian Hu, Nikhil Mittal, et al.
Npj Aging|January 23, 2024
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and agingAnnet Nicole Linders, Itamar Braga Dias, Teresa López Fernández, et al.
Journal of Clinical Medicine|January 11, 2022
Iron Deficiency in Heart Failure: Mechanisms and PathophysiologyRidha I S Alnuwaysir, Martijn F Hoes, Dirk J van Veldhuisen, et al.
JACC. Basic to Translational Science|September 19, 2024
Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER MalformationNienke M Stege, Rudolf A de Boer, Catherine A Makarewich, et al.
Pageof 42